Corewell Health at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Corewell Health brings 4 presentations to IDWeek 2026 in Washington. Its program centres on serious bacterial infections and what predicts death from them, along with gut infections. One study looks at the barriers and administrative delays that faced bezlotoxumab, a since-discontinued Clostridioides difficile therapy.
| Organization | IDWeek 2026 Attendance |
|---|---|
Poster Fri Oct 23 12:15pm–1:30pm Eight-Year Retrospective Study of MDR Pathogens and 90-Day Mortality in Culture-Positive Acute Cholangitis Poster Sat Oct 24 12:15pm–1:30pm A Post-marketing Portrait of Bezlotoxumab Use – Potential Barriers and Administrative Delays of a Discontinued therapy for Clostridiodes difficile Infection Poster Sat Oct 24 12:15pm–1:30pm Perforated Gastric Ulcer Caused by Gastrointestinal Mucormycosis Poster Sat Oct 24 12:15pm–1:30pm Source Matters: Pneumonia as a Predictor of Mortality in Group A Streptococcal Bacteremia |
Instantly find 20 buyers from Corewell Health
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction